ArticleThoracic cancer2024

Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective.

Fuqiang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.